The embodiments disclosed herein relate to minimally invasive orthopedic procedures, and more particularly to photodynamic bone stabilization systems for use in repairing a weakened or fractured bone.
Bone fracture repairs are surgical procedures to realign and stabilize broken bones, and are conventionally carried out using plates, nails, screws or pins. Current methods of treating bone fractures each have significant drawbacks. For example, tendon adhesions are typical in casting; soft tissue injury occurs frequently when plates or screws are inserted during open surgery; and K-wires do not provide sufficient support for immediate movement. Frequently, these procedures require extensive post operative recuperation and present with co-morbidities, such as, stiffness and loss of range of motion. For example, post surgical soft tissue injury can reduce mobility, and callous may incorporate into surrounding tendons further reducing mobility.
Photodynamic bone stabilization systems are disclosed herein. According to aspects illustrated herein, a photodynamic bone stabilization system includes a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium.
According to aspects illustrated herein, a photodynamic bone stabilization system includes a light-conducting fiber configured to transmit light energy; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy; a pressurizing medium configured to control polymerization shrinkage; and a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween, wherein the catheter comprises an inner void and an inner lumen, wherein the inner void is sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, wherein the inner lumen is sufficiently designed to pass the light-conducting fiber into the expandable portion, and wherein the inner lumen comprises expandable portions configured to expand when the pressurizing medium is delivered to the inner lumen so as to cause internal diameter pressure against the light-sensitive liquid monomer contained within the expandable portion during polymerization.
According to aspects illustrated herein, a method includes providing a system comprising a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy, to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium; inserting the expandable portion of the system into an intramedullary canal spanning a fracture site comprising a plurality of fractured pieces; infusing the light-sensitive liquid monomer into the inner void of the catheter so that the light-sensitive liquid monomer expands the expandable portion until the fractured pieces are substantially restored to their natural positions; inserting the light-conducting fiber into the inner lumen of the catheter so that the light-conducting fiber resides in the expandable portion; activating the light-conducting fiber to transmit light energy to the expandable portion to initiate in situ polymerization of the light-sensitive liquid monomer within the expandable portion; infusing the cooling medium into the inner lumen of the catheter to control polymerization temperature; and completing the in situ polymerization of the light-sensitive liquid monomer to harden the expandable portion at the fracture site.
The presently disclosed embodiments will be further explained with reference to the attached drawings, wherein like structures are referred to by like numerals throughout the several views. The drawings shown are not necessarily to scale, with emphasis instead generally being placed upon illustrating the principles of the presently disclosed embodiments.
While the above-identified drawings set forth presently disclosed embodiments, other embodiments are also contemplated, as noted in the discussion. This disclosure presents illustrative embodiments by way of representation and not limitation. Numerous other modifications and embodiments can be devised by those skilled in the art which fall within the scope and spirit of the principles of the presently disclosed embodiments.
The embodiments disclosed herein relate to minimally invasive orthopedic procedures, and more particularly to photodynamic bone stabilization systems for use in repairing a weakened or fractured bone. In an embodiment, a photodynamic bone stabilization system includes a thin-walled, non-compliant, expandable portion releasably mounted on a small diameter, flexible insertion catheter. In an embodiment, the expandable portion is adapted to reside within an inner cavity of at least two bone fragments and provide support to the bone fragments. In an embodiment, the expandable portion is adapted to reside within an inner cavity of at least two bone fragments and secure the bone fragments in a relatively fixed relationship to each another, thus ensuring that the fractured bone can regenerate in the proper orientation and fuse the fracture.
In an embodiment, a photodynamic bone stabilization system of the present disclosure is used to treat a fracture including, but not limited to, a hand fracture, a wrist fracture, a radius fracture, an ulna fracture, a clavicle fracture, a metacarpal fracture, a phalanx fracture, a metatarsal fracture, a phalange fracture, a tibia fracture, a fibula fracture, a humerus fracture, and a rib fracture. Long bones are the large bones in the arms and legs, and include the humerus, the radius/ulna, the femur and the tibia/fibula. In an embodiment, a photodynamic bone stabilization system of the present disclosure is used to reinforce a fractured long bone. In an embodiment, a photodynamic bone stabilization system of the present disclosure is used to stabilize a fractured long bone in conjunction with anatomic reduction (i.e., proper reorientation of fractured elements to their original position, both relative to one another and relative to other adjacent anatomical features).
In an embodiment, a syringe housing light-sensitive liquid is attached to the adapter 135 at the proximal end 112 of the insertion catheter 101, and during use of the photodynamic bone stabilization system, the syringe plunger is pushed, allowing the syringe to expel the light-sensitive liquid into an inner void 110 (not visible in
In an embodiment, a light-conducting fiber communicating light from a light source is introduced into adapter 115 at the proximal end 112 of the insertion catheter 101 to pass the light-conducting fiber within an inner lumen 120 (not visible in
The optical fiber can be made from any material, such as glass, silicon, silica glass, quartz, sapphire, plastic, combinations of materials, or any other material, and may have any diameter, as not all embodiments of the present disclosure are intended to be limited in this respect. In an embodiment, the optical fiber is made from a polymethyl methacrylate core with a transparent polymer cladding. The optical fiber can have a diameter between approximately 0.75 mm and approximately 2.0 mm. In some embodiments, the optical fiber can have a diameter of about 0.75 mm, about 1 mm, about 1.5 mm, about 2 mm, less than about 0.75 mm or greater than about 2 mm as not all embodiments of the present disclosure are intended to be limited in this respect. In an embodiment, the optical fiber is made from a polymethyl methacrylate core with a transparent polymer cladding. It should be appreciated that the above-described characteristics and properties of the optical fibers are exemplary and not all embodiments of the present disclosure are intended to be limited in these respects. Light energy from a visible emitting light source can be transmitted by the optical fiber. In an embodiment, visible light having a wavelength spectrum of between about 380 nm to about 780 nm, between about 400 nm to about 600 nm, between about 420 nm to about 500 nm, between about 430 nm to about 440 nm, is used to cure the light-sensitive liquid.
The light-sensitive liquid remains a liquid monomer until activated by the light-conducting fiber (cures on demand). Radiant energy from the light-conducting fiber is absorbed and converted to chemical energy to quickly polymerize the monomer. This cure affixes the expandable portion in an expanded shape. A cure may refer to any chemical, physical, and/or mechanical transformation that allows a composition to progress from a form (e.g., flowable form) that allows it to be delivered through the inner void in the insertion catheter 101, into a more permanent (e.g., cured) form for final use in vivo. For example, “curable” may refer to uncured composition, having the potential to be cured in vivo (as by catalysis or the application of a suitable energy source), as well as to a composition in the process of curing (e.g., a composition formed at the time of delivery by the concurrent mixing of a plurality of composition components).
The presently disclosed embodiments provide expandable portions of photodynamic bone stabilization systems of the present disclosure. It should be understood that any of the expandable portions disclosed herein may include one or more radiopaque markers or bands. For example, a radiopaque ink bead may be placed at a distal end of the expandable portion for alignment of the system during fluoroscopy. The one or more radiopaque bands and radiopaque ink bead, using radiopaque materials such as barium sulfate, tantalum, or other materials known to increase radiopacity, allows a medical professional to view the expandable portion during positioning to properly position the expandable during a repair procedure, and allows the medical professional to view the expandable portion during inflation and/or deflation to properly stabilize and align the fractured bones. In an embodiment, the one or more radiopaque bands permit visualization of any voids that may be created by air that gets entrapped in the expandable portion. In an embodiment, the one or more radiopaque bands permit visualization to preclude the expandable portion from misengaging or not meeting a bone due to improper inflation to maintain a uniform expandable/bone interface.
It should be understood that any of the expandable portions disclosed herein may be round, flat, cylindrical, oval, rectangular or any desired shape for a given application. The expandable portion may be formed of a pliable, resilient, conformable, and strong material, including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable portion is constructed out of a PET nylon aramet or other non-consumable materials. In an embodiment, the expandable portion may be formed from a material that allows the expandable portion to conform to obstructions or curves at the site of implantation.
It should be understood that any of the expandable portions disclosed herein by way of example, but not of limitation, can have the following dimensions: In an embodiment, the expandable portion has a diameter ranging from about 5 mm to about 20 mm. In an embodiment, the expandable portion has a length ranging from about 20 mm to about 450 mm. In an embodiment, the expandable portion has a diameter of about 5 mm and a length of about 30 mm. In an embodiment, the expandable portion has a diameter of about 5 mm and a length of about 40 mm. In an embodiment, the expandable portion has a diameter of about 6 mm and a length of about 30 mm. In an embodiment, the expandable portion has a diameter of about 6 mm and a length of about 40 mm. In an embodiment, the expandable portion has a diameter of about 6 mm and a length of about 50 mm. In an embodiment, the expandable portion has a diameter of about 7 mm and a length of about 30 mm. In an embodiment, the expandable portion has a diameter of about 7 mm and a length of about 40 mm. In an embodiment, the expandable portion has a diameter of about 7 mm and a length of about 50 mm. In an embodiment, the expandable portion has a diameter of about 14 mm and a length of about 400 mm. In an embodiment, the expandable portion has a diameter of about 14 mm and a length of about 300 mm.
It should be understood that any of the expandable portions disclosed herein includes an outer surface that, in an embodiment, may be coated with materials or additives such as drugs, bone glue, proteins, growth factors, or other natural or synthetic coatings (for example, radiopaque or ultrasonically active materials). For example, after a minimally invasive surgical procedure an infection may develop in a patient, requiring the patient to undergo antibiotic treatment. An antibiotic drug may be added to the outer surface of the expandable portion to prevent or combat a possible infection. Proteins, such as, for example, bone morphogenic protein or other growth factors have been shown to induce the formation of cartilage and bone. A growth factor may be added to the outer surface of the expandable portion to help induce the formation of new bone. Due to the lack of thermal egress of the light-sensitive liquid in the expandable portion, the effectiveness and stability of the coating is maintained.
It should be understood that the expandable portions disclosed herein typically do not have any valves. One benefit of having no valves is that the expandable portion may be inflated or deflated as much as necessary to assist in the fracture reduction and placement. Another benefit of the expandable portion having no valves is the efficacy and safety of the system. Since there is no communication passage of light-sensitive liquid to the body there cannot be any leakage of liquid because all the liquid is contained within the expandable portion. In an embodiment, a permanent seal is created between the expandable portion that is both hardened and affixed prior to the insertion catheter being removed. The expandable portion may have valves, as all of the embodiments are not intended to be limited in this manner.
It should be understood that the expandable portions disclosed herein include an outer surface that is resilient and puncture resistant. In an embodiment, the outer surface of the expandable portion is substantially even and smooth. In an embodiment, the outer surface of the expandable portion is not entirely smooth and may have some small bumps or convexity/concavity along the length. In an embodiment, the outer surface of the expandable portion may have ribs, ridges, bumps or other shapes. In an embodiment, the expandable portion has a textured surface which provides one or more ridges that allow grabbing. In an embodiment, abrasively treating the outer surface of the expandable portion via chemical etching or air propelled abrasive media improves the connection and adhesion between the outer surface of the expandable portion and the bone. The surfacing significantly increases the amount of surface area that comes in contact with the bone resulting in a stronger grip.
One possible side effect of curing a light-sensitive liquid is polymerization shrinkage. The presently disclosed embodiments provide photodynamic bone stabilization systems sufficiently designed to control polymerization shrinkage that may occur in an expandable portion of the system during use.
The inner lumen 120 passes through the longitudinal axis of the flexible insertion catheter 101 and the expandable portion 200. The inner lumen 120 is sufficiently designed to pass a light-conducting fiber. The inner void 110 exists between an outer surface of the inner lumen 120 and an inner surface 130 of the insertion catheter 101; and an outer surface of the inner lumen 120 and an inner surface 230 of the expandable portion 200 and provides a passageway for light-sensitive liquid to travel.
During a procedure for repairing a weakened to fractured long bone, the expandable portion 200 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 200 and begins to expand or inflate the expandable portion 200. The expandable portion 200 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 200 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 200 is determined, the light-conducting fiber is positioned in the inner lumen 120 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 200 which will polymerize or cure the light-sensitive liquid. There is the potential that during in situ curing of the light-sensitive liquid, areas of the expandable portion 200 that are not in the immediate vicinity of the polymerization process may exhibit polymerization shrinkage upon cure of about 2 to about 3 percent. This may be especially relevant when the expandable portion 200 is used to reduce and stabilize a long bone, where the expandable portion 200 may have a diameter ranging from about 13 mm to about 20 mm and a length ranging from about 100 mm to about 450 mm. To prevent shrinkage from occurring, the inner lumen 120 in the expandable portion 200 can be pressurized by virtue of the infusion of either air or other fluids (e.g., saline or water) to cause internal diameter pressure against the light-sensitive liquid contained within the expandable portion 200 so that during the curing, the pressure keeps the light-sensitive liquid pressurized, and up in contact with inner walls 230 of the expandable portion 200. In some embodiments, the inner lumen 120 in the expandable portion 200 is configured to include areas 224 which are capable of expanding when pressurized with air or other fluids.
In an embodiment, the inner lumen 120 in the expandable portion 200 includes one area 224 configured to prevent the effects of polymerization shrinkage during curing of the light-sensitive liquid. In an embodiment, the inner lumen 120 in the expandable portion 200 includes two areas 224 configured to prevent the effects of polymerization shrinkage during curing of the light-sensitive liquid. As illustrated in
One possible side effect of curing a light-sensitive liquid besides polymerization shrinkage is temperature rise. The temperature rise is in direct relation with the strength of polymerization light intensity. For instance, as intensity grows, so does the temperature. The presently disclosed embodiments provide photodynamic bone stabilization systems sufficiently designed to control temperature rise that may occur in an expandable portion of the system during use. In an embodiment, the photodynamic bone stabilization systems include an expandable portion sufficiently designed to move from a deflated state to an inflated state when a light-sensitive liquid is delivered to the expandable portion. Once proper positioning and expansion of the expandable portion is determined, the light-sensitive liquid can be cured in situ to harden the expandable portion thus providing a rigid orthopedic stabilizer. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered so as to cool the expandable portion during the curing process. Cooling medium for use with a photodynamic bone stabilization system of the present disclosure includes, but is not limited to, gases, liquids and combinations thereof. Examples of gases include, but are not limited to, inert gases and air. Examples of liquids include, but are not limited to, water, saline, saline-ice mixtures, liquid cryogen. In an embodiment, the cooling medium is water. The cooling medium can be delivered to the expandable portion at room temperature or at a cooled temperature. In an embodiment, the cooling medium improves the numerical aperture between that of the light-conducting fiber and the inner lumen for the light-conducting fiber because it is desirable to take up the air between the light-conducting fiber and the material of the expandable portion so as to improve light transmission. Therefore, the light transmission will be light-conducting fiber—cooling media—expandable portion—light-sensitive liquid as opposed to light-conducting fiber—air—expandable portion—light-sensitive liquid. In an embodiment, the cooling medium transmitted through the inner lumen takes away extraneous heat.
In the embodiment illustrated in
During a procedure for repairing a weakened to fractured long bone, the expandable portion 300 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 300 and begins to expand or inflate the expandable portion 300. The expandable portion 300 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 300 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 300 is determined, the light-conducting fiber is positioned in the inner lumen 120 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 300 which will polymerize or cure the light-sensitive liquid. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion 300 to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered through the inner lumen 120 concurrently with the light-conducting fiber, so as to cool the expandable portion 300 during the curing process.
In the embodiment illustrated in
During a procedure for repairing a weakened or fractured long bone, the expandable portion 500 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 500 and begins to expand or inflate the expandable portion 500. The expandable portion 500 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 500 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 500 is determined, the light-conducting fiber is positioned in the septum lumen 130 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 500 which will polymerize or cure the light-sensitive liquid. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion 500 to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered through the cooling medium intake lumen 122 so as to cool the expandable portion 500 during the curing process. The cooling medium is removed from the photodynamic bone stabilization system via the cooling medium return lumen 124.
In the embodiment illustrated in
During a procedure for repairing a weakened to fractured long bone, the expandable portion 600 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 600 and begins to expand or inflate the expandable portion 600. The expandable portion 600 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 600 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 600 is determined, the light-conducting fiber is positioned in the inner lumen 120 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 600 which will polymerize or cure the light-sensitive liquid. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion 600 to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered through the external helical tubing 680 so as to cool the expandable portion 600 from the outside during the curing process.
In an embodiment, a method for repairing a fractured bone in a patient using a photodynamic bone stabilization system sufficiently designed to control temperature rise that may occur during use includes: a minimally invasive incision is made through a skin of the patient to expose the fractured bone. The incision may be made at the proximal end or the distal end of the fractured bone to expose a bone surface. Once the bone surface is exposed, it may be necessary to retract some muscles and tissues that may be in view of the fractured bone. At least a first proximal access hole is formed in the fractured bone by drilling or other methods known in the art. The first proximal access hole extends through a hard compact outer layer of the fractured bone into the relatively porous inner or cancellous tissue. For bones with marrow, the medullary material should be cleared from the medullary cavity prior to insertion of the insertion catheter. Marrow is found mainly in the flat bones such as hip bone, breast bone, skull, ribs, vertebrae and shoulder blades, and in the cancellous material at the proximal ends of the long bones like the femur and humerus. Once the medullary cavity is reached, the medullary material including air, blood, fluids, fat, marrow, tissue and bone debris should be removed to form a void. The void is defined as a hollowed out space, wherein a first position defines the most distal edge of the void with relation to the penetration point on the bone, and a second position defines the most proximal edge of the void with relation to the penetration site on the bone. The bone may be hollowed out sufficiently to have the medullary material of the medullary cavity up to the cortical bone removed. In an embodiment, such as when the expandable portion 300 of
Once orientation of the bone fragments are confirmed to be in a desired position, the light-sensitive liquid may be cured within the expandable portion, such as by illumination with a visible emitting light source. In an embodiment, visible light having a wavelength spectrum of between about 380 nm to about 780 nm, between about 400 nm to about 600 nm, between about 420 nm to about 500 nm, between about 430 nm to about 440 nm, is used to cure the light-sensitive liquid. In an embodiment, the addition of the light causes the photoinitiator in the light-sensitive liquid, to initiate the polymerization process: monomers and oligomers join together to form a durable biocompatible crosslinked polymer. In an embodiment, the cure provides complete 360 degree radial and longitudinal support and stabilization to the fractured bone. During this curing, a syringe housing the cooling medium is attached to the proximal end of the insertion catheter and continuously delivered to the expandable portion. When the expandable portion 300 of
In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to selectively stiffen an expandable portion of the system during use. In an embodiment, a photodynamic bone stabilization system of the present disclosure includes an expandable portion having a plurality of stiffening members. In an embodiment, the plurality of stiffening members are disposed along the length of the expandable portion. In an embodiment, the plurality of stiffening members are disposed along the length of an outer surface of the expandable portion. In an embodiment, the plurality of stiffening members are disposed along the length of an inner surface of the expandable portion. The stiffening members can be secured to the expandable portion in a variety of ways. For example and not limitation, the stiffening members can be secured to an adapter, e.g., luer, hub, manifold, or a reinforcement or filler material, or support member. Alternatively, the stiffening members can be secured to the expandable portion by way of an engagement member. In this manner, an engagement member can be secured to the surface of the expandable portion such that a space or cavity is defined for engaging the stiffening members. In an embodiment, the expandable portion includes a plurality of stiffening members configured to control or vary axial flexibility along a length of the expandable portion. In an embodiment, the expandable portion includes a plurality of stiffening members that can be disposed radially and/or axially.
In an embodiment, the stiffening members or metallic pieces may protrude or extend from the expandable portion such that the metallic pieces extend beyond the diameter of the expandable portion. In an embodiment, stiffening members or metallic pieces may be situated within the expandable portion such that the diameter of the expandable portion may be substantially maintained. In an embodiment, stiffening members or metallic pieces may be integral with the expandable portion such that the expandable portion and the stiffening members are contiguous with one another. In an embodiment, stiffening members or metallic pieces may be attached, coupled, covered, sheathed, or otherwise connected to the expandable portion. In an embodiment, the stiffening members or metallic pieces may be contiguous with one another so as to form one structure around the expandable portion. In an embodiment, the stiffening members or metallic pieces can be separate and distinct so as to form multiple structures around the expandable portion. In an embodiment, the stiffening members or metallic pieces are circumferentially connected to one another at a distal end and a proximal end forming end plates. In an embodiment, the end plates help maintain the structure of the stiffening members or metallic pieces when the expandable portion is expanded.
In an embodiment, the stiffening members or metallic pieces may alter or change their configuration under a temperature change. In an embodiment, the metallic pieces expand outwards against the bone at the site of fracture. In an embodiment, the metallic pieces can expand to increase the strength of the hardened expandable potion. In an embodiment, the metallic pieces can contract to increase the strength of the hardened expandable potion. In an embodiment, an inner surface of the metallic pieces (those surfaces that are in contact with the external circumferential surface of the expandable portion) are polished to increase internal reflection of the light from the light-conducting fiber. In an embodiment, the metallic pieces are sufficiently designed to be load-bearing shapes. In an embodiment, the metallic pieces have a low profile and can handle large loads. In an embodiment, the metallic pieces may produce a greater amount of force on a large area than a small area. In an embodiment, the metallic pieces may produce a greater amount of force in a tight or narrow space that in a shallow or open space.
As illustrated in the embodiments of
In an embodiment, two metallic memory-type metal wires 1050, such as nitonol, are positioned within the expandable portion 500 from
The present disclosure provides photodynamic bone stabilization systems and methods for reinforcing bone. In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to control polymerization shrinkage that may occur in an expandable portion of the system during use. In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to control temperature rise that may occur in an expandable portion of the system during use. In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to selectively stiffen an expandable portion of the system during use. It should be understood that the benefits provided by each of the photodynamic bone stabilization systems disclosed herein, including means to control polymerization shrinkage, means to control temperature rise, and means to selectively stiffen, can be used alone or combination. For example, in an embodiment, a photodynamic bone stabilization system of the present disclosure includes means for both controlling polymerization shrinkage and for controlling temperature rise. In an embodiment, a photodynamic bone stabilization system of the present disclosure includes means for both controlling temperature rise and means to selectively stiffen (as disclosed
In an embodiment, a photodynamic bone stabilization system includes an insertion catheter having an elongated shaft with a proximal end, a distal end, and a longitudinal axis therebetween, the insertion catheter having an inner void for passing a light-sensitive liquid, an inner lumen for accepting a light-conducting fiber, and a pathway sufficiently designed for passing a cooling medium; an expandable portion releasably engaging the distal end of the insertion catheter, the expandable portion moving from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable portion; and adapters releasably engaging the proximal end of the insertion catheter for receiving the light-conducting fiber, the light-sensitive liquid, and the cooling medium.
In an embodiment, a photodynamic bone stabilization system includes an insertion catheter having an elongated shaft with a proximal end, a distal end, and a longitudinal axis therebetween, the insertion catheter having an inner void for passing a light-sensitive liquid, and an inner lumen for accepting a light-conducting fiber, the inner lumen sufficiently designed to be pressurized by virtue of infusion of air, fluid, or combinations thereof; an expandable portion releasably engaging the distal end of the insertion catheter, the expandable portion moving from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable portion; and adapters releasably engaging the proximal end of the insertion catheter for receiving the light-conducting fiber, the light-sensitive liquid, and the air or fluid, wherein the infusion of the air or fluid causes internal diameter pressure against the light-sensitive liquid contained within the expandable portion so that during a curing process, pressure keeps the light-sensitive liquid pressurized, and up in contact with inner walls of the expandable portion.
In an embodiment, a photodynamic bone stabilization system includes an insertion catheter having an elongated shaft with a proximal end, a distal end, and a longitudinal axis therebetween, the insertion catheter having an inner void for passing a light-sensitive liquid, and an inner lumen for accepting a light-conducting fiber; an expandable portion releasably engaging the distal end of the insertion catheter, the expandable portion moving from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable portion; stiffening members engaging the expandable portion; and adapters releasably engaging the proximal end of the insertion catheter for receiving the light-conducting fiber and the light-sensitive liquid.
In an embodiment, a photodynamic bone stabilization system includes a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium.
In an embodiment, a photodynamic bone stabilization system includes a light-conducting fiber configured to transmit light energy; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy; a pressurizing medium configured to control polymerization shrinkage; and a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween, wherein the catheter comprises an inner void and an inner lumen, wherein the inner void is sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, wherein the inner lumen is sufficiently designed to pass the light-conducting fiber into the expandable portion, and wherein the inner lumen comprises expandable portions configured to expand when the pressurizing medium is delivered to the inner lumen so as to cause internal diameter pressure against the light-sensitive liquid monomer contained within the expandable portion during polymerization.
In an embodiment, a method includes providing a system comprising a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy, to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium; inserting the expandable portion of the system into an intramedullary canal spanning a fracture site comprising a plurality of fractured pieces; infusing the light-sensitive liquid monomer into the inner void of the catheter so that the light-sensitive liquid monomer expands the expandable portion until the fractured pieces are substantially restored to their natural positions; inserting the light-conducting fiber into the inner lumen of the catheter so that the light-conducting fiber resides in the expandable portion; activating the light-conducting fiber to transmit light energy to the expandable portion to initiate in situ polymerization of the light-sensitive liquid monomer within the expandable portion; infusing the cooling medium into the inner lumen of the catheter to control polymerization temperature; and completing the in situ polymerization of the light-sensitive liquid monomer to harden the expandable portion at the fracture site.
All patents, patent applications, and published references cited herein are hereby incorporated by reference in their entirety. It will be appreciated that several of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or application. Various presently unforeseen or unanticipated alternatives, modifications, variations, or improvements therein may be subsequently made by those skilled in the art.
This application is a continuation of U.S. patent application Ser. No. 12/755,784, filed on Apr. 7, 2010, which claims priority to and the benefit of U.S. Provisional Patent Application No. 61/167,276, filed on Apr. 7, 2009, the entireties of all these applications are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4280233 | Raab | Jul 1981 | A |
4294251 | Greenwald et al. | Oct 1981 | A |
4313434 | Segal | Feb 1982 | A |
4341691 | Anuta | Jul 1982 | A |
4369772 | Miller | Jan 1983 | A |
4414608 | Furihata | Nov 1983 | A |
4422719 | Orcutt | Dec 1983 | A |
4433898 | Nasiri | Feb 1984 | A |
4462394 | Jacobs | Jul 1984 | A |
4466435 | Murray | Aug 1984 | A |
4562598 | Kranz | Jan 1986 | A |
4686973 | Frisch | Aug 1987 | A |
4697584 | Haynes | Oct 1987 | A |
4735625 | Davidson | Apr 1988 | A |
4870953 | DonMicheal et al. | Oct 1989 | A |
4888024 | Powlan | Dec 1989 | A |
4904391 | Freeman | Feb 1990 | A |
4961424 | Kubota et al. | Oct 1990 | A |
4963151 | Ducheyne et al. | Oct 1990 | A |
4969888 | Scholten et al. | Nov 1990 | A |
5030093 | Mitnick | Jul 1991 | A |
5049157 | Mittelmeier et al. | Sep 1991 | A |
5085660 | Lin | Feb 1992 | A |
5092899 | Forte | Mar 1992 | A |
5102413 | Poddar | Apr 1992 | A |
5108404 | Scholten et al. | Apr 1992 | A |
5112333 | Fixel | May 1992 | A |
5295733 | LeBegue | Mar 1994 | A |
5295962 | Crocker et al. | Mar 1994 | A |
5303718 | Krajicek | Apr 1994 | A |
5316550 | Forte | May 1994 | A |
5336699 | Cooke et al. | Aug 1994 | A |
5372598 | Luhr et al. | Dec 1994 | A |
5391144 | Sakurai et al. | Feb 1995 | A |
5415654 | Daikuzono | May 1995 | A |
5423850 | Berger | Jun 1995 | A |
5432876 | Appeldorn et al. | Jul 1995 | A |
5443468 | Johnson | Aug 1995 | A |
5462552 | Kiester | Oct 1995 | A |
5480400 | Berger | Jan 1996 | A |
5538514 | Hawkins | Jul 1996 | A |
5548676 | Savage, Jr. | Aug 1996 | A |
5554111 | Morrey et al. | Sep 1996 | A |
5556429 | Felt | Sep 1996 | A |
5571204 | Nies | Nov 1996 | A |
5658310 | Berger | Aug 1997 | A |
5658963 | Qian et al. | Aug 1997 | A |
5705181 | Cooper et al. | Jan 1998 | A |
5707374 | Schmidt | Jan 1998 | A |
5713901 | Tock | Feb 1998 | A |
5795353 | Felt | Aug 1998 | A |
5824087 | Aspden et al. | Oct 1998 | A |
5827289 | Reiley et al. | Oct 1998 | A |
5888220 | Felt et al. | Mar 1999 | A |
5897557 | Chin et al. | Apr 1999 | A |
5908433 | Eager et al. | Jun 1999 | A |
5972015 | Scribner et al. | Oct 1999 | A |
5980075 | Sheaffer | Nov 1999 | A |
5980253 | Oxman et al. | Nov 1999 | A |
5987199 | Zarian et al. | Nov 1999 | A |
5989230 | Frassica | Nov 1999 | A |
6008264 | Ostler et al. | Dec 1999 | A |
6019761 | Gustilo | Feb 2000 | A |
6019774 | Weiss et al. | Feb 2000 | A |
6033411 | Preissman | Mar 2000 | A |
6039762 | McKay | Mar 2000 | A |
6042380 | De Rowe | Mar 2000 | A |
6048346 | Reiley et al. | Apr 2000 | A |
6059789 | Dinger et al. | May 2000 | A |
6066154 | Reiley et al. | May 2000 | A |
6079868 | Rydell | Jun 2000 | A |
6103203 | Fischer | Aug 2000 | A |
6110176 | Shapira | Aug 2000 | A |
6121341 | Sawhney et al. | Sep 2000 | A |
6127597 | Beyar et al. | Oct 2000 | A |
6140452 | Felt et al. | Oct 2000 | A |
6159236 | Biel | Dec 2000 | A |
6179852 | Strickland et al. | Jan 2001 | B1 |
6195477 | Denuto et al. | Feb 2001 | B1 |
6200134 | Kovac et al. | Mar 2001 | B1 |
6217581 | Tolson | Apr 2001 | B1 |
6223085 | Dann et al. | Apr 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6235043 | Reiley et al. | May 2001 | B1 |
6241734 | Scribner et al. | Jun 2001 | B1 |
6248110 | Reiley et al. | Jun 2001 | B1 |
6248131 | Felt et al. | Jun 2001 | B1 |
6258089 | Campbell et al. | Jul 2001 | B1 |
6261289 | Levy | Jul 2001 | B1 |
6280456 | Scribner et al. | Aug 2001 | B1 |
6282013 | Ostler et al. | Aug 2001 | B1 |
6290382 | Bourn et al. | Sep 2001 | B1 |
6299597 | Buscemi et al. | Oct 2001 | B1 |
6306177 | Felt et al. | Oct 2001 | B1 |
6319255 | Grundei et al. | Nov 2001 | B1 |
6332894 | Stalcup et al. | Dec 2001 | B1 |
6336914 | Gillespie, III | Jan 2002 | B1 |
6336930 | Stalcup et al. | Jan 2002 | B1 |
6358252 | Shapira | Mar 2002 | B1 |
6387098 | Cole et al. | May 2002 | B1 |
6395007 | Bhatnagar et al. | May 2002 | B1 |
6416531 | Chen | Jul 2002 | B2 |
6416737 | Manolagas et al. | Jul 2002 | B1 |
6419483 | Adam et al. | Jul 2002 | B1 |
6423083 | Reiley et al. | Jul 2002 | B2 |
6425923 | Stalcup et al. | Jul 2002 | B1 |
6440444 | Boyce et al. | Aug 2002 | B2 |
6443988 | Felt et al. | Sep 2002 | B2 |
6447514 | Stalcup et al. | Sep 2002 | B1 |
6458375 | Gertzman et al. | Oct 2002 | B1 |
6478751 | Krueger et al. | Nov 2002 | B1 |
6485512 | Cheng | Nov 2002 | B1 |
6494883 | Ferree | Dec 2002 | B1 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6524313 | Fassier et al. | Feb 2003 | B1 |
6551321 | Burkinshaw et al. | Apr 2003 | B1 |
6551337 | Rabiner et al. | Apr 2003 | B1 |
6565528 | Mueller | May 2003 | B1 |
6579277 | Rabiner et al. | Jun 2003 | B1 |
6579279 | Rabiner et al. | Jun 2003 | B1 |
6620185 | Harvie et al. | Sep 2003 | B1 |
6623505 | Scribner et al. | Sep 2003 | B2 |
6632235 | Weikel et al. | Oct 2003 | B2 |
6648881 | KenKnight et al. | Nov 2003 | B2 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6652587 | Felt et al. | Nov 2003 | B2 |
6660013 | Rabiner et al. | Dec 2003 | B2 |
6679873 | Rabiner et al. | Jan 2004 | B2 |
6695781 | Rabiner et al. | Feb 2004 | B2 |
6695782 | Rabiner et al. | Feb 2004 | B2 |
6696073 | Boyce et al. | Feb 2004 | B2 |
6716216 | Boucher et al. | Apr 2004 | B1 |
6719773 | Boucher et al. | Apr 2004 | B1 |
6726691 | Osorio et al. | Apr 2004 | B2 |
6730048 | Hare et al. | May 2004 | B1 |
6733451 | Rabiner et al. | May 2004 | B2 |
6733513 | Boyle et al. | May 2004 | B2 |
6740093 | Hochschuler et al. | May 2004 | B2 |
6755862 | Keynan | Jun 2004 | B2 |
6783530 | Levy | Aug 2004 | B1 |
6802835 | Rabiner et al. | Oct 2004 | B2 |
6818018 | Sawhney | Nov 2004 | B1 |
6852095 | Ray | Feb 2005 | B1 |
6866678 | Shenderova et al. | Mar 2005 | B2 |
6869442 | Cheng | Mar 2005 | B2 |
6875212 | Shaolian et al. | Apr 2005 | B2 |
6885246 | Tsutsui et al. | Apr 2005 | B2 |
6887246 | Bhatnagar et al. | May 2005 | B2 |
6887275 | Carchidi et al. | May 2005 | B2 |
6899713 | Shaolian et al. | May 2005 | B2 |
6899719 | Reiley et al. | May 2005 | B2 |
6932843 | Smith et al. | Aug 2005 | B2 |
6964667 | Shaolian et al. | Nov 2005 | B2 |
6979341 | Scribner et al. | Dec 2005 | B2 |
6981981 | Reiley et al. | Jan 2006 | B2 |
7001431 | Bao et al. | Feb 2006 | B2 |
7008433 | Voellmicke et al. | Mar 2006 | B2 |
7052498 | Levy et al. | May 2006 | B2 |
7077865 | Bao et al. | Jul 2006 | B2 |
7124067 | Ascenzi | Oct 2006 | B2 |
7141061 | Williams et al. | Nov 2006 | B2 |
7144414 | Harvie et al. | Dec 2006 | B2 |
7153305 | Johnson et al. | Dec 2006 | B2 |
7156861 | Scribner et al. | Jan 2007 | B2 |
7156880 | Evans et al. | Jan 2007 | B2 |
7169140 | Kume | Jan 2007 | B1 |
7215863 | Arenella et al. | May 2007 | B1 |
7241303 | Reiss et al. | Jul 2007 | B2 |
7258692 | Thelen et al. | Aug 2007 | B2 |
7261720 | Stevens et al. | Aug 2007 | B2 |
7320709 | Felt et al. | Jan 2008 | B2 |
7341601 | Eisermann et al. | Mar 2008 | B2 |
7360542 | Nelson et al. | Apr 2008 | B2 |
7407616 | Melikechi et al. | Aug 2008 | B2 |
7419450 | Ito | Sep 2008 | B2 |
7427295 | Ellman et al. | Sep 2008 | B2 |
7547319 | Segal et al. | Jun 2009 | B2 |
7628800 | Sherman et al. | Dec 2009 | B2 |
7632277 | Woll et al. | Dec 2009 | B2 |
7632291 | Stephens et al. | Dec 2009 | B2 |
7666205 | Weikel et al. | Feb 2010 | B2 |
7722620 | Truckai et al. | May 2010 | B2 |
7744555 | DiMauro et al. | Jun 2010 | B2 |
7766965 | Bao et al. | Aug 2010 | B2 |
7771476 | Justis et al. | Aug 2010 | B2 |
7776075 | Bruneau et al. | Aug 2010 | B2 |
7806900 | Rabiner | Oct 2010 | B2 |
7811284 | Rabiner | Oct 2010 | B2 |
7811286 | Medoff | Oct 2010 | B2 |
7811290 | Rabiner | Oct 2010 | B2 |
7842040 | Rabiner et al. | Nov 2010 | B2 |
7850711 | Stone et al. | Dec 2010 | B1 |
7879041 | Rabiner et al. | Feb 2011 | B2 |
7912539 | Doty et al. | Mar 2011 | B2 |
7947015 | Herweck et al. | May 2011 | B2 |
8034071 | Scribner et al. | Oct 2011 | B2 |
8123807 | Kim | Feb 2012 | B2 |
8210729 | O'Leary et al. | Jul 2012 | B2 |
8246628 | Rabiner | Aug 2012 | B2 |
8328402 | O'Leary et al. | Dec 2012 | B2 |
8348956 | Rabiner | Jan 2013 | B2 |
8366711 | Rabiner et al. | Feb 2013 | B2 |
8403968 | Rabiner et al. | Mar 2013 | B2 |
8512338 | Rabiner et al. | Aug 2013 | B2 |
20010011174 | Reiley et al. | Aug 2001 | A1 |
20010044626 | Reiley et al. | Nov 2001 | A1 |
20020156482 | Scribner et al. | Oct 2002 | A1 |
20020161373 | Osorio et al. | Oct 2002 | A1 |
20020198526 | Shaolian et al. | Dec 2002 | A1 |
20030028210 | Boyle et al. | Feb 2003 | A1 |
20030083642 | Boyd et al. | May 2003 | A1 |
20030105469 | Karmon | Jun 2003 | A1 |
20030114914 | Cheng | Jun 2003 | A1 |
20030156431 | Gozum et al. | Aug 2003 | A1 |
20030199850 | Chavez et al. | Oct 2003 | A1 |
20030212426 | Olson et al. | Nov 2003 | A1 |
20030229372 | Reiley et al. | Dec 2003 | A1 |
20040006341 | Shaolian et al. | Jan 2004 | A1 |
20040024388 | Altshuler | Feb 2004 | A1 |
20040034434 | Evans et al. | Feb 2004 | A1 |
20040059333 | Carl et al. | Mar 2004 | A1 |
20040059417 | Smith et al. | Mar 2004 | A1 |
20040092948 | Stevens et al. | May 2004 | A1 |
20040098015 | Weikel et al. | May 2004 | A1 |
20040117025 | Reindel | Jun 2004 | A1 |
20040133280 | Trieu | Jul 2004 | A1 |
20040167561 | Boucher et al. | Aug 2004 | A1 |
20040167625 | Beyar et al. | Aug 2004 | A1 |
20040225296 | Reiss et al. | Nov 2004 | A1 |
20040228142 | Takada et al. | Nov 2004 | A1 |
20040230309 | Di Mauro et al. | Nov 2004 | A1 |
20040247641 | Felt et al. | Dec 2004 | A1 |
20050010231 | Myers | Jan 2005 | A1 |
20050015140 | deBeer | Jan 2005 | A1 |
20050015148 | Jansen et al. | Jan 2005 | A1 |
20050043733 | Eisermann et al. | Feb 2005 | A1 |
20050043808 | Felt et al. | Feb 2005 | A1 |
20050049691 | Mericle et al. | Mar 2005 | A1 |
20050090901 | Studer | Apr 2005 | A1 |
20050119662 | Reiley et al. | Jun 2005 | A1 |
20050142315 | DeSimone et al. | Jun 2005 | A1 |
20050149022 | Shaolian et al. | Jul 2005 | A1 |
20050159749 | Levy et al. | Jul 2005 | A1 |
20050171604 | Michalow | Aug 2005 | A1 |
20050192671 | Bao et al. | Sep 2005 | A1 |
20050197711 | Cachia | Sep 2005 | A1 |
20050228260 | Burwell et al. | Oct 2005 | A1 |
20050234453 | Shaolian et al. | Oct 2005 | A1 |
20050251140 | Shaolian et al. | Nov 2005 | A1 |
20050284485 | Nelson et al. | Dec 2005 | A9 |
20060009550 | Messersmith et al. | Jan 2006 | A1 |
20060015105 | Warren et al. | Jan 2006 | A1 |
20060036253 | Leroux et al. | Feb 2006 | A1 |
20060084985 | Kim et al. | Apr 2006 | A1 |
20060100547 | Rabiner et al. | May 2006 | A1 |
20060100635 | Reiley et al. | May 2006 | A1 |
20060100706 | Shadduck et al. | May 2006 | A1 |
20060111726 | Felt et al. | May 2006 | A1 |
20060122625 | Truckai et al. | Jun 2006 | A1 |
20060155296 | Richter | Jul 2006 | A1 |
20060173464 | Ellman et al. | Aug 2006 | A1 |
20060183811 | Melikechi et al. | Aug 2006 | A1 |
20060184246 | Zwirkoski | Aug 2006 | A1 |
20060195165 | Gertner et al. | Aug 2006 | A1 |
20060217747 | Ferree | Sep 2006 | A1 |
20060229617 | Meller et al. | Oct 2006 | A1 |
20060247787 | Rydell et al. | Nov 2006 | A1 |
20060253102 | Nance et al. | Nov 2006 | A1 |
20060253200 | Bao et al. | Nov 2006 | A1 |
20060258981 | Eidenschink | Nov 2006 | A1 |
20060264950 | Nelson et al. | Nov 2006 | A1 |
20060264951 | Nelson et al. | Nov 2006 | A1 |
20060264952 | Nelson et al. | Nov 2006 | A1 |
20060265077 | Zwirkoski | Nov 2006 | A1 |
20060271061 | Beyar et al. | Nov 2006 | A1 |
20060276793 | Berry | Dec 2006 | A1 |
20060276819 | Osorio et al. | Dec 2006 | A1 |
20060282169 | Felt et al. | Dec 2006 | A1 |
20060287730 | Segal et al. | Dec 2006 | A1 |
20070027547 | Rydell et al. | Feb 2007 | A1 |
20070067032 | Felt et al. | Mar 2007 | A1 |
20070087031 | Ashman et al. | Apr 2007 | A1 |
20070118143 | Ralph et al. | May 2007 | A1 |
20070123876 | Czartoski et al. | May 2007 | A1 |
20070123877 | Goldin et al. | May 2007 | A1 |
20070123878 | Shaver et al. | May 2007 | A1 |
20070161991 | Altarac et al. | Jul 2007 | A1 |
20070198023 | Sand et al. | Aug 2007 | A1 |
20070225705 | Osario et al. | Sep 2007 | A1 |
20070255287 | Rabiner | Nov 2007 | A1 |
20080015500 | Herweck et al. | Jan 2008 | A1 |
20080021474 | Bonutti et al. | Jan 2008 | A1 |
20080039854 | Rabiner | Feb 2008 | A1 |
20080080205 | Forrester et al. | Apr 2008 | A1 |
20080103505 | Fransen | May 2008 | A1 |
20080125784 | Rabiner et al. | May 2008 | A1 |
20080154368 | Justis et al. | Jun 2008 | A1 |
20080154373 | Protopsaltis et al. | Jun 2008 | A1 |
20080183122 | Fisher et al. | Jul 2008 | A1 |
20080188858 | Luzzi et al. | Aug 2008 | A1 |
20080234820 | Felt et al. | Sep 2008 | A1 |
20080249529 | Zarda et al. | Oct 2008 | A1 |
20080255560 | Myers et al. | Oct 2008 | A1 |
20080269750 | Justin | Oct 2008 | A1 |
20080287951 | Stoneburner et al. | Nov 2008 | A1 |
20090018524 | Greenhalgh et al. | Jan 2009 | A1 |
20090024166 | Carl et al. | Jan 2009 | A1 |
20090048629 | Rabiner | Feb 2009 | A1 |
20090054900 | Rabiner et al. | Feb 2009 | A1 |
20090093887 | Walter et al. | Apr 2009 | A1 |
20090112196 | Rabiner et al. | Apr 2009 | A1 |
20090171265 | Doty et al. | Jul 2009 | A1 |
20090171358 | Chang et al. | Jul 2009 | A1 |
20090177204 | Colleran et al. | Jul 2009 | A1 |
20090182336 | Brenzel et al. | Jul 2009 | A1 |
20090187192 | Rabiner et al. | Jul 2009 | A1 |
20090216232 | Buford, III et al. | Aug 2009 | A1 |
20090228007 | Justin et al. | Sep 2009 | A1 |
20090254064 | Boatman | Oct 2009 | A1 |
20090287309 | Walch et al. | Nov 2009 | A1 |
20100234958 | Linares | Sep 2010 | A1 |
20100249942 | Goswami et al. | Sep 2010 | A1 |
20100256641 | Rabiner et al. | Oct 2010 | A1 |
20100262069 | Rabiner et al. | Oct 2010 | A1 |
20100262188 | Rabiner et al. | Oct 2010 | A1 |
20100265733 | O'Leary et al. | Oct 2010 | A1 |
20100318087 | Scribner et al. | Dec 2010 | A1 |
20100331850 | Rabiner | Dec 2010 | A1 |
20110004213 | Rabiner et al. | Jan 2011 | A1 |
20110009871 | Rabiner | Jan 2011 | A1 |
20110029093 | Bojarski et al. | Feb 2011 | A1 |
20110046746 | Rabiner et al. | Feb 2011 | A1 |
20110098713 | Rabiner et al. | Apr 2011 | A1 |
20110110114 | Papac et al. | May 2011 | A1 |
20110118740 | Rabiner et al. | May 2011 | A1 |
20110160870 | Baumgartner et al. | Jun 2011 | A1 |
20110166306 | Stansbury et al. | Jul 2011 | A1 |
20110313356 | Rabiner et al. | Dec 2011 | A1 |
20120165941 | Rabiner et al. | Jun 2012 | A1 |
20120262939 | O'Leary et al. | Oct 2012 | A1 |
20120289968 | Rabiner | Nov 2012 | A1 |
20130003406 | O'Leary et al. | Jan 2013 | A1 |
20130006304 | Rabiner et al. | Jan 2013 | A1 |
20130013008 | Rabiner et al. | Jan 2013 | A1 |
20130013009 | Colleran et al. | Jan 2013 | A1 |
20130013010 | Rabiner et al. | Jan 2013 | A1 |
20130023876 | Rabiner et al. | Jan 2013 | A1 |
20130023886 | Rabiner et al. | Jan 2013 | A1 |
20130041472 | Rabiner et al. | Feb 2013 | A1 |
20130046390 | Rabiner et al. | Feb 2013 | A1 |
20130066326 | Rabiner et al. | Mar 2013 | A1 |
20130158607 | Rabiner et al. | Jun 2013 | A1 |
20130184715 | Rabiner et al. | Jul 2013 | A1 |
Number | Date | Country |
---|---|---|
40 28 466 | Mar 1992 | DE |
0 709 698 | May 1996 | EP |
2001-527437 | Dec 2001 | JP |
2004-526525 | Sep 2002 | JP |
2005-511143 | Apr 2005 | JP |
2006-212425 | Aug 2006 | JP |
9001858 | Mar 1992 | NL |
WO 9838918 | Sep 1998 | WO |
WO 0243628 | Jun 2002 | WO |
WO 03047472 | Jun 2003 | WO |
WO 2004045393 | Jun 2004 | WO |
WO 2004058045 | Jul 2004 | WO |
WO 2004073563 | Sep 2004 | WO |
WO 2004112661 | Dec 2004 | WO |
WO 2005112804 | Dec 2005 | WO |
WO 2006016807 | Feb 2006 | WO |
WO 2007059259 | May 2007 | WO |
WO 2007127255 | Nov 2007 | WO |
WO 2007127260 | Nov 2007 | WO |
WO 2008063265 | May 2008 | WO |
WO 2009059090 | May 2009 | WO |
WO 2009082688 | Jul 2009 | WO |
WO 2009131999 | Oct 2009 | WO |
WO 2010050965 | May 2010 | WO |
WO 2010118158 | Oct 2010 | WO |
WO 2011060062 | May 2011 | WO |
WO 2011071567 | Jun 2011 | WO |
WO 2011162910 | Dec 2011 | WO |
WO 2012088432 | Jun 2012 | WO |
WO 2013013069 | Jan 2013 | WO |
WO 2013013071 | Jan 2013 | WO |
WO 2013013072 | Jan 2013 | WO |
WO2013059609 | Apr 2013 | WO |
Entry |
---|
Jovanovic et al., “Fixion Nails for Humeral Fractures, Injury”, Int. J. Care Injured, vol. 35, Issue 11, pp. 1140-1142, Nov. 2004. |
Maruyama et al., “Metacarpal Fracture Fixation with Absorbable Polyglycolide Rods and Stainless Steel K Wires: A Biomechanical Comparison”, Journal of Biomedical Materials Research (Applied Biomaterials), vol. 33, Issue 1, pp. 9-12, Apr. 1996. |
Waris et al., “Bioabsorbable Miniplating Versus Metallic Fixation for Metacarpal Fractures”, Clinical Orthopaedics and Related Research, No. 410, pp. 310-319, May 2003. |
Waris et al., “Self-Reinforced Bioabsorbable Versus Metallic Fixation Systems for Metacarpal and Phalangeal Fractures: A Biomechanical Study”, The Journal of Hand Surgery, vol. 27A, No. 5, pp. 902-909, Sep. 2002. |
PCT International Search Report based on PCT/US07/20402 dated Apr. 1, 2008. |
PCT International Search Report based on PCT/US07/10050 dated Apr. 17, 2008. |
PCT International Search Report based on PCT/US07/10038 dated Aug. 27, 2008. |
PCT International Search Report based on PCT/US08/81929 dated Jan. 12, 2009. |
PCT International Search Report based on PCT/US08/81924 dated Feb. 9, 2009. |
PCT International Search Report based on PCT/US08/87630 dated Feb. 24, 2009. |
PCT International Search Report based on PCT/US10/30275 dated Aug. 11, 2010. |
PCT International Search Report based on PCT/US10/56219 dated Jan. 20, 2011. |
PCT International Search Report based on PCT/US10/46003 dated May 24, 2011. |
PCT International Search Report based on PCT/US11/38389 dated Sep. 22, 2011. |
PCT International Search Report based on PCT/US11/66871 dated May 1, 2012. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 29, 2009. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Mar. 11, 2010. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 30, 2010. |
USPTO Office Action in U.S. Appl. No. 11/789,907 mailed May 11, 2010. |
USPTO Office Action in U.S. Appl. No. 11/903,123 mailed Jul. 1, 2010. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Dec. 9, 2010. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Apr. 28, 2011. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Sep. 23, 2011. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Mar. 16, 2012. |
USPTO Office Action in U.S. Appl. No. 12/262,411 mailed Sep. 1, 2010. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Dec. 23, 2011. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed May 11, 2012. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Oct. 24, 2011. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Apr. 4, 2012. |
USPTO Office Action in U.S. Appl. No. 12/875,460 mailed Mar. 8, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Dec. 27, 2011. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed May 29, 2012. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Jun. 8, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Jun. 26, 2012. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Jul. 6, 2012. |
Extended European Search Report based on EP 07 75 6022 dated Jul. 30, 2012. |
Extended European Search Report based on EP 07 75 6016 dated Jul. 30, 2012. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Aug. 1, 2012. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Aug. 2, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Aug. 15, 2012. |
PCT International Search Report based on PCT/US12/47447 dated Oct. 2, 2012. |
PCT International Search Report based on PCT/US12/47446 dated Oct. 15, 2012. |
PCT International Search Report based on PCT/US12/47444 dated Oct. 18, 2012. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Oct. 25, 2012. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Nov. 9, 2012. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Dec. 3, 2012. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jan. 17, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Dec. 14, 2012. |
International Search Report and Written Opinion for PCT/US2012/061047 mailed Jan. 7, 2013. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Jan. 22, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Jan. 23, 2013. |
USPTO Office Action in U.S. Appl. No. 13/772,947 mailed Jun. 19, 2013. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jul. 9, 2013. |
Supplemental European Search Report based on EP 08 87 7881 dated May 15, 2013. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Feb. 4, 2013. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Mar. 13, 2013. |
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Apr. 23, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Apr. 26, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed May 13, 2013. |
Number | Date | Country | |
---|---|---|---|
20130023877 A1 | Jan 2013 | US |
Number | Date | Country | |
---|---|---|---|
61167276 | Apr 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12755784 | Apr 2010 | US |
Child | 13616416 | US |